Correspondence | Published:

Pre-transplant recovery of microbiome diversity without recovery of the original microbiome

Bone Marrow Transplantation (2018) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer. 2018;18:283–95.

  2. 2.

    Andermann T, Peled J, Ho C, Reddy P, Riches M, Storb R, et al. Microbiome-host interactions in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2018. https://doi.org/10.1016/j.bbmt.2018.02.009.

  3. 3.

    Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120:4332–41.

  4. 4.

    Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55:905–14.

  5. 5.

    Haak BW, Littmann ER, Chaubard J-L, Pickard AJ, Fontana E, Adhi F, et al. Impact of gut colonization with butyrate producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018;131:blood-2018-01-828996.

  6. 6.

    Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505–13.

  7. 7.

    Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, et al. Intestinal blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21:1373–83.

  8. 8.

    Weber D, Jenq RR, Peled JU, Taur Y, Hiergeist A, Koestler J, et al. Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:845–52.

  9. 9.

    Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016;8:339ra71–339ra71.

  10. 10.

    Taur Y, Jenq RR, Perales M-A, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124:1174–82.

  11. 11.

    Shannon CE, Weaver W. The mathematical theory of communication. Urbana, IL: The University of Illinois Press; 1949.

  12. 12.

    Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci. 2011;108:4554–61.

  13. 13.

    Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA. The application of ecological theory toward anunderstanding of the human microbiome. Science. 2012;336:1255–62.

  14. 14.

    Paine RT, Tegner MJ, Johnson EA. Compounded perturbations yield ecological surprises. Ecosystems. 1998;1:535–45.

  15. 15.

    Bray JR, Curtis JT. An ordination of the upland forest communities of southern Wisconsin. Ecol Monogr. 1957;27:325–49.

Download references

Acknowledgements

A University of Minnesota Medical School Innovation grant (to AR), a University of Minnesota Foundation grant (to AR), and funding from Achieving Cures Together and Hubbard Foundation supported this research. We thank Markas Welke, Andrea Hoeschen and Kevin Olson for coordinating sample collections. Sequence data were processed and analyzed using the resources of the Minnesota Supercomputing Institute.

Author information

Affiliations

  1. Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA

    • Armin Rashidi
    • , Shernan G. Holtan
    •  & Daniel J. Weisdorf
  2. Department of Surgery, University of Minnesota, Minneapolis, MN, USA

    • Thomas Kaiser
    •  & Christopher Staley
  3. BioTechnology Institute, University of Minnesota, St. Paul, MN, USA

    • Thomas Kaiser
    • , Alexander Khoruts
    •  & Christopher Staley
  4. Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Minnesota, Minneapolis, MN, USA

    • Alexander Khoruts

Authors

  1. Search for Armin Rashidi in:

  2. Search for Thomas Kaiser in:

  3. Search for Shernan G. Holtan in:

  4. Search for Daniel J. Weisdorf in:

  5. Search for Alexander Khoruts in:

  6. Search for Christopher Staley in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Armin Rashidi.

Electronic supplementary material

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41409-018-0414-z